BVMF/C2RS34 (BVMF/C2RS34)

Brazil Stock Exchange: BVMF/C2RS34 · BRL

R$31.0

+0.00 (0.0%)· Recorded snapshot

Market cap	25.8B
Revenue (ttm)	69.4M
Net income (ttm)	-2.3B
EPS (ttm)	-R$3.18
Volume	20
Beta	1.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.4M
Net income (ttm): -2.3B
EPS (ttm): -R$3.18
Market cap: 25.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-26.1

P25 n/aP50 n/aP75 n/a

ROIC-325.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/C2RS34 indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Switzerland
Country code	BR
Earnings date	2026-11-03
Employees	393
Employees change	-14
Employees growth	-3.44%
Enterprise value	BRL 17.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	2013
Industry	Biotechnology
Is primary listing	No
ISIN number	BRC2RSBDR005
Last refreshed	2026-10-29
Market cap	BRL 25.8B
Next earnings date	2026-11-03
Price	BRL 31.00
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/C2RS34
Website	https://www.crisprtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.26%
EV/Sales	272.66x
FCF / EV yield	-9.81%
FCF yield	-6.84%
P/B ratio	3.11x
P/S ratio	405.18x
Price / tangible book value	3.11x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-3,971.53%
Pretax margin	-3,346.08%
Profit per employee	BRL -5.9M
Revenue per employee	BRL 176,543
ROA	-14.2%
ROA (5Y)	-8.33%
ROCE	-21.12%
ROE	-26.09%
ROE (5Y)	-13.88%
ROIC	-325.94%
ROIC (5Y)	-91.82%
SBC / revenue	510.16%
Tax / revenue	22.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	-64.8%
Revenue growth (Q)	1,041.37%
Revenue growth (QoQ)	598.29%
Revenue growth 10Y	24.32%
Revenue growth 3Y	-57.14%
Revenue growth 5Y	-56.91%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -9M
Depreciation and amortization	BRL 99.9M
EBIT	BRL -2.8B
EBITDA	BRL -2.7B
EPS	BRL -3.18
Financing cash flow	BRL 5.2B
Free cash flow	BRL -1.9B
Free cash flow minus SBC	BRL -2.3B
Gross profit	BRL -2.4B
Income taxes	BRL 15.7M
Investing cash flow	BRL -2.8B
Net borrowing	BRL 3.2B
Net cash flow	BRL 488.1M
Net income	BRL -2.3B
Operating cash flow minus SBC	BRL -2.3B
Operating income	BRL -2.8B
Revenue	BRL 69.4M
Stock-based compensation	BRL 354M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.68
Book value per share	BRL 93.61
Debt / equity	0.45
Long-term assets	BRL 1.1B
Long-term liabilities	BRL 4B
Net cash (debt)	BRL 8.2B
Net cash / market cap	29.13%
Net cash growth	4.97%
Net debt / equity	-0.9
Piotroski F-Score	2
Property, plant and equipment	BRL 1.2B
Shareholders' equity	BRL 9B
Tangible book value	BRL 9B
Tangible book value per share	BRL 93.61
Total assets	BRL 13.7B
Total cash	BRL 12.2B
Total debt	BRL 4.1B
Total liabilities	BRL 4.7B
WACC	12.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	BRL 12.7B
Current liabilities	BRL 710.6M
Current ratio	17.85
Net working capital	BRL -553.5M
Quick ratio	17.79
Working capital	BRL 11.6B
Working capital turnover	0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.33%
Shareholder yield	-10.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 34.83
1D price change	0%
1M price change	-11.43%
1M total return	-11.43%
1W price change	-1.96%
1W total return	-1.96%
1Y price change	-31.94%
1Y return CAGR	-31.96%
1Y total return	-31.94%
20-day SMA	BRL 33.51
200-day SMA	BRL 36.50
3M price change	0.39%
3M total return	0.39%
3Y price change	24%
3Y return CAGR	7.43%
3Y total return	24%
50-day SMA	BRL 33.83
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 44.29
52-week high date	2025-10-28
52-week low	BRL 29.91
52-week low date	2026-05-21
6M price change	-1.15%
6M total return	-1.15%
All-time high	BRL 58.40
All-time high date	2022-07-20
All-time low	BRL 22.48
All-time low date	2025-04-07
Average true range (ATR)	BRL 0.97
Average volume	120
Beta (5Y)	1.76
Change from 52-week high	-30.01%
Change from 52-week low	3.64%
Change from all-time high	-46.92%
Change from all-time low	37.9%
Change from open	0%
Day's gap	0%
Dollar volume	BRL 620
High price	BRL 31.00
Low price	BRL 31.00
Monthly RSI	49.11
Open price	BRL 31.00
Previous close	BRL 31.00
Price vs 150-day SMA	-11%
Price vs 20-day SMA	-7.49%
Price vs 200-day SMA	-15.07%
Price vs 50-day SMA	-8.36%
Relative volume	0.17
RSI	51.73
Sharpe ratio	0.6
Sortino ratio	1.18
Volume	20
Weekly RSI	49.04
YTD price change	-17.9%
YTD total return	-17.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96.2M
Shares change (QoQ)	0.48%
Shares change (YoY)	10.33%
Shares held by insiders	0.53%
Shares held by institutions	78.95%
Short ratio	10.7 days

Deeper analysis on BVMF/C2RS34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/C2RS34 report

Is a complete BVMF/C2RS34 research report available?

No complete published report is available for bvmf/C2RS34 (BVMF/C2RS34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/C2RS34 (BVMF/C2RS34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/C2RS34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/C2RS34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/C2RS34

Frequently asked questions